These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 4518740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R.
    Schweiz Med Wochenschr; 1974 Mar 09; 104(10):356-64. PubMed ID: 4206521
    [No Abstract] [Full Text] [Related]

  • 3. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW, Allan GW, Smith J, Tyrell WF, Fallon RJ.
    Chest; 1972 Jun 09; 61(6):579-82. PubMed ID: 4260668
    [No Abstract] [Full Text] [Related]

  • 4. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
    Beji M, Louzir B, Ben Rhomdane N, Zouari M, Mtimet B, Daghfous J.
    Tunis Med; 1995 May 09; 73(5):201-3. PubMed ID: 9507284
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rifampicin hepatitis. A clinical and histological study.
    Scheuer PJ, Summerfield JA, Lal S, Sherlock S.
    Lancet; 1974 Mar 16; 1(7855):421-5. PubMed ID: 4131429
    [No Abstract] [Full Text] [Related]

  • 7. Short-course chemotherapy. The Arkansas experience.
    Dutt AK, Stead WW.
    Chest; 1981 Dec 16; 80(6):724-7. PubMed ID: 7030655
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct 16; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 9. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
    Smith J, Tyrell WF, Gow A, Allan GW, Lees AW.
    Chest; 1972 Jun 16; 61(6):587-8. PubMed ID: 5032153
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis].
    Fokina LV, Vusygina RN, Antosik OD.
    Probl Tuberk; 1976 Feb 16; (21):34-9. PubMed ID: 1264980
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hepatoxic side-effects of rifampicin. A comparative clinical study].
    Kuntz HD, Rausch V.
    Med Welt; 1977 Nov 25; 28(47):1940-2. PubMed ID: 342868
    [No Abstract] [Full Text] [Related]

  • 15. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R, Doster BE, Murray FJ, Woolpert SF.
    Am Rev Respir Dis; 1974 Feb 25; 109(2):216-32. PubMed ID: 4204541
    [No Abstract] [Full Text] [Related]

  • 16. Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
    Bobrowitz ID.
    Lung; 1980 Feb 25; 157(3):117-25. PubMed ID: 7382540
    [No Abstract] [Full Text] [Related]

  • 17. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V, Catena E, Delli Veneri F, De Michele G, Marra A.
    Am Rev Respir Dis; 1971 Mar 25; 103(3):329-37. PubMed ID: 5005040
    [No Abstract] [Full Text] [Related]

  • 18. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H, Eule H, Lau W, Kuhnert R, Fanter D, Kahlau U, Schönert E, Werner E.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 Mar 25; 138(1):146-58. PubMed ID: 4491712
    [No Abstract] [Full Text] [Related]

  • 19. Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin.
    Wäre M, Heinivaara O, Elo R, Tala E.
    Scand J Respir Dis Suppl; 1969 Mar 25; 69():59-63. PubMed ID: 4906375
    [No Abstract] [Full Text] [Related]

  • 20. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S, Sasaki M, Kobayashi T, Matsuda T.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep 25; 19(2):84-8. PubMed ID: 4649627
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.